Henry Schein (HSIC) Scheduled to Post Quarterly Earnings on Tuesday

Henry Schein (NASDAQ:HSIC) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, August 6th. Analysts expect the company to announce earnings of $1.27 per share for the quarter. Henry Schein has set its FY24 guidance at $5.00 to $5.16 EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period in the prior year, the business earned $1.21 EPS. On average, analysts expect Henry Schein to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Henry Schein Price Performance

Shares of NASDAQ HSIC opened at $71.02 on Monday. The firm has a market cap of $9.09 billion, a PE ratio of 23.99, a PEG ratio of 1.80 and a beta of 0.87. The company has a current ratio of 1.75, a quick ratio of 1.02 and a debt-to-equity ratio of 0.47. Henry Schein has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a fifty day moving average price of $68.03 and a 200 day moving average price of $71.78.

Analyst Ratings Changes

Several brokerages have commented on HSIC. Evercore ISI cut their price target on shares of Henry Schein from $75.00 to $72.00 and set an “in-line” rating on the stock in a research report on Tuesday, July 9th. Barrington Research reissued an “outperform” rating and set a $92.00 price target on shares of Henry Schein in a research report on Friday, July 5th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Robert W. Baird raised shares of Henry Schein from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $81.00 to $92.00 in a research report on Monday, July 22nd. Finally, Piper Sandler reissued an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. One investment analyst has rated the stock with a sell rating, six have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $81.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.